Open innovation has become the main trend in pharmaceutical research. Potential obstacles and pitfalls of collaborations often lead to missed opportunities and/or poorly executed partnerships. This paper aims to provide a framework that facilitates the execution of successful collaborations. We start by mapping out three checkpoints onto early-stage collaborative partnerships: inception, ignition and implementation. Different value types and value drivers are then laid out for each phase of the partnership. We proceed to propose a ratio-driven approach and a value-adjustment mechanism, enhancing the probability of successes in pharmaceutical research collaborations. These guiding principles combined should help the partners either reach agreement more quickly or move on to the next potential project.

开放式创新已成为药物研究的主要趋势。合作的潜在障碍和陷阱通常导致错过机会和/或执行不力的伙伴关系。本文旨在提供一个框架，以促进成功的协作的执行。我们首先将三个检查点规划到早期的合作伙伴关系中：成立，启动和实施。然后为伙伴关系的每个阶段布置不同的价值类型和价值驱动力。我们继续提出比率驱动的方法和价值调整机制，以提高药物研究合作成功的可能性。这些指导原则相结合应有助于合作伙伴更快地达成协议或继续进行下一个潜在项目。